Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us

Eli Lilly expands D2C offerings to reach Alzheimer’s patients

The news: Eli Lilly is adding tools to its D2C platform that connect Alzheimer’s patients with virtual care and other resources.

Catch up quick: The drugmaker’s D2C website, LillyDirect, lets patients select telehealth providers treating certain disease states (e.g., obesity, migraines) who can prescribe Eli Lilly’s medications. LillyDirect also serves as an online pharmacy, delivering its medications to patients’ homes.

Here’s what’s new: Lilly’s recently FDA-approved Alzheimer’s infusion treatment, Kisunla, can’t be received via virtual care or through an online pharmacy like other conditions supported by LillyDIrect.

You've read 0 of 2 free articles this month.

Create an account for uninterrupted access to select articles.
Create a Free Account